DAFTAR RUJUKAN
1. Parkin M, Tyczynski JE, Boffetta P, Samet J, Shields P, Caporaso N. Lung cancer epidemiology and etiology. In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. (Eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press Lyon; 2004.p.14-17
2. French CA. Respiratory Tract. In : Cibas ES, Ducatman BS.(eds). Cytology: Diagnostic Principles Clinical Correlates. 3rd ed. Elsevier. Philadelphia. 2009; p.89-100
3. Gaur DS, Thapliyal NC, Kishore S, Pathak VP. Efficacy of broncho-alveolar lavage and bronchial brush cytology in diagnosing lung cancers. Jurnal of Cytology. 2007; 24 (24): 73-7. Diunduh pada tanggal 3 Pebruari 2010;12.16.PM
4. Lamb C. Bronchial washing, bronchoalveolar lavage, bronchial brush, and endobronchial biopsy. In: Ernst A. (Ed). Introduction to Bronchoscopy. Cambridge University Press; 2009. p.85-97
5. Kasuma D. Profil penderita yang dilakukan tindakan bronkoskopi serat optik lentur di instalasi diagnostik terpadu (IDT) RSUP H. Adam Malik Medan. http://repository.usu.ac.id/handle/123456789/17044. Diunduh pada tanggal 11 September 2012; 11.21 AM
6. Chang HH, Dreyfuss JM, Ramoni MF. A transcriptional network signature characterizes lung cancer subtypes. Cancer. 2011 January 15; 117(2): 353–60. Diunduh pada tanggal 16 April 2012; 5.25 PM
7. Stenhouse G, Fyfe N, King G, Chapman A, Kerr KM. Thyroid transcription factor 1 in pulmonary adenocarcinoma. J Clin Pathol. 2004;57:383–7. Diunduh pada tanggal 16 Agustus 2012; 3.30 PM.
8. Kwei KA, Kim YH, Girard L, Kao J, Pacyna-Gengelbach M, Salari K. Genomic profiling identifies titf1as a lineage-specific oncogene amplified in lung cancer. Oncogene. 2008; June 5; 27(25): 3635–40. Diunduh pada tanggal 16 Agustus 2012; 3.40 PM
10.Ray MR, Jablons D, He B. Lung cancer therapeutics that target signaling pathways: an update. Expert Rev Respir Med. 2010 October ; 4(5): 631–45. Diunduh pada tanggal 16 Agustus 2012; 4.46 PM
11.Sadler TW. Respiratory System. In: Langman’s Medical Embryology. 8th Ed. p.278-88
12.Warburton D, El-Hashash A, Carraro G, Tiozzo C, Sala F, Rogers O. Lung organogenesis. Curr Top Dev Biol. 2010 ; 90: 73–158. doi:10.1016/S0070-2153(10)90003-3. Diunduh pada tanggal 21Mei 2012; 1.20 PM
13.Ellis H. Clinical Anatomy. 11th ed. Blackwell Publishing Ltd; 2006:19-27
14.Bourke SJ. Anatomy And Physiology of The Lungs. In: Respiratory Medicine. 6th Ed. Blackwell Publishing Ltd; 2003. p.1-7
15.Tank PW, Gest TR. Lippincott Williams & Wilkins Atlas of Anatomy. 1st Edition. Lippincott Williams & Wilkins; 2009. p.189-91
16.Jika tidak dikendalikan 26 juta orang di dunia menderita kanker . Pusat Komunikasi Publik, Sekretariat Jenderal Kementerian Kesehatan RI. 2011. Diunduh dari: http://depkes.go.id. Diunduh pada tanggal 3 September 2012; 7.31 PM
17.Tyczy ski JE, Parkin DM. Global epidemiology of lung cancer. In: Hirsch FR, Bunn PA, Kato H, Mulshine JL.(Eds). Textbook of Prevention and Detection of Early Lung Cancer. Taylor & Francis. 1st Ed; 2006. p.1-18
18.Petersen I. The Morphological and Molecular Diagnosis of Lung Cancer. Dtsch Arztebl Int 2011; 108(31–32):525–31. DOI: 10.3238/arztebl.2011.0525. Diunduh pada tanggal 16 April 2012; 4.56 PM
19.Sleimana M, Gundela LA, Pankowb JF, III PJ, Singera BC, Destaillatsa H. Formation of carcinogens indoors by surface-mediated reactions of nicotine with nitrous acid, leading to potential thirdhand smoke hazards. PNAS. 2010;107(15):6576-81. Diunduh pada tanggal 22 Oktober 2012; 04.40 AM
20.Sozzi G, Andriani F, Roz L, Dragani TA, Manenti G, Gariboldi M, et al. Lung carcinogenesis: biology. In: Hirsch FR, Bunn PA, Kato H, Mulshine JL.(Eds). Textbook of Prevention and Detection of Early Lung Cancer. Taylor & Francis. 1st Ed.;2006. p.96-123.
22.Travis W, Nicholson S, Hirsch FR, Pugatch B, Geisinger K, Brambilla E, et al. Small cell carcinoma. In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. (Eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press Lyon; 2004. p.33-6
23.Husain AN, Kumar V. The lung. In: In : Kumar V, Abbas A, Faust N. (Eds.). Robbins and Cotran’s Pathologic Basis of Disease. 7th ed. Philadelphia: WB Saunders; 2007. p.711-72
24.Melamed MR. Tumors of the lung: conventional cytology and aspiration biopsy In: Koss LG, Melamed MR.(Eds). Koss’ Diagnostic Cytology and Its Histopathologic Bases. Vol. II. 5th Ed. Lipincott William & Wilkins; 2006. p.644-83
25.Yoshizawa A, Motoi N, Riely GJ, Sima CS, Gerald WL, Kris MG, et al. Impact Of Proposed IASLC/ATS/ERS Classification of Lung Adenocarcinoma: Prognostic Subgroups and Implications for Further Revision of Staging Based on Analysis of 514 Stage I Cases. Modern Pathology. 2011; 24: 653–64. Diunduh pada tanggal 7 September 2012; 4.04 AM
26.Mackinnon AC, Husain AN. Lung And Pleura.In: Differential Diagnosis In Surgical Pathology. Gattuso P, Reddy VB, David O, Spitz DJ, Haber MH.(Eds). Elsevier. 2nd ed; 2010. p.261-3
27.Gazdar AF. Should We Continue to Use The Term Non-Small-Cell LungCancer? Annals of Oncology. 2010; 21 (Supplement 7): vii225–9. doi:10.1093/annonc/mdq372. Diunduh pada tanggal 7 September 2012; 4.42 AM
28.Ohori P, Rami-Porta R, Franks T, Shimosato Y, Matsuno Y, Khoor A. et al.
Adenocarcinoma. In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. (Eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press Lyon; 2004. P.37-46
29.Johnston WW, Elson CE. Respiratory tract. In: Bibbo M, Wilbur DC. (Eds). Comprehensive Cytopathology. 3rd eds Elsevier; 2008.p.332-50
30.Hasegawal C, Nakayama H, Kameda1 Y, Yamada K, Isobe T. Stromal micropapillary component as a novel unfavorable prognostic factor of lung adenocarcinoma. Diagnostic Pathology. 2012;7:3. Diunduh pada tanggal 28 Juli 2013; 09.04 PM
31.Ohe M, Yokose1 T, Sakuma Y, Miyagi Y, Okamoto N, Osanai S,Hasegawa1C, et al. Stromal micropapillary component as a novel unfavorable prognostic factor of lung
32.Barletta JA,Yeap BY,Chirieac LR. The prognostic significance of grading in lung
adenocarcinoma. Cancer. 2010 February 1; 116(3): 659–69. Diunduh pada tanggal 28 Juli 2013; 09.59 PM
33.Solis LM, Behrens C, Raso G, Lin HY, Kadara H, Yuan P, Galindo H, et al. Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome. Cancer. 2012 June 1; 118(11): 2889–99. Diunduh pada tanggal 28 Juli 2013; 09.55 PM
34.Prudence A. Russell PA, Wainer Z, Wright GM, Daniels M,Conron M,et al. Does lung adenocarcinoma subtype predict patient survival? a clinicopathologic study based on the New International Association for the Study of Lung Cancer/American Thoracic Society/ European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification. J Thorac Oncol.2011;6: 1496–1504. Diunduh pada tanggal 7 September 2012; 4.23 AM
35.Hammar SP, Brambilla C,PugatchB, Geisinger K, Fernandez EA, Vogt P.Squamous cell carcinoma. In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. (Eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press Lyon; 2004.p.28-32
36.Brambilla E, Pugatch B, Geisinger K, Gal A, Sheppard MN, Guinee DG, et al. Large cell carcinoma. In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. (Eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press Lyon; 2004.p.47-52
37.Hirsch FR, Corrin B, Colby TV. Clinical features and staging. In: Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. (Eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press Lyon; 2004.p.18-21
38.Erasmus JJ, Leung AN. Current concepts in diagnosis and staging of lung cancer. In: J. Hodler J, von Schulthess GK, Zollikofer Ch.L.(Eds). Diseases of the Heart, Chest & Breast. Diagnostic Imaging and Interventional Techniques. Springer; 2007.p.3-10
39.Gaspar LE, Schefter T. Non-surgical approaches to early-stage non-small-cell lung cancer (NSCLC). In: Hirsch FR, Bunn PA, Kato H, Mulshine JL.(Eds). Textbook of Prevention and Detection of Early Lung Cancer. Taylor & Francis. 1st Ed; 2006.p.312-39
28(3):173–94. doi:10.1007/s12325-010-0103-9. Diunduh pada tanggal 16 Agustus 2012; 4.26 PM
41.Osmon SB, Mayse M. Bronchoscopy. In : Shiffren A, Lin TL.(Eds). The Washington Manual Subspecialty Consult-Pulmonary Medicine Subspecialty Consult; Lippincott Williams & Wilkins, Washington USA.2003;4:28-34.
42.Stanzel F, Haussinger K. Fluorescence bronchoscopy. In : Beamis JF, Mehta AC, Mathur PN. (Eds). Interventional Pulmonary Medicine; Marcel Dekker Inc; New York-USA; 2004 (18): 355-84.
43.Alamoudi OS, Attar SM, Ghabrah TM, Kassimi MA. Bronchoscopy, indications, safety and complications. Saudi Medical Journal 2000; Vol. 21 (11): 1043-7. Diunduh pada tanggal 11 September 2012; 03.35 PM
44.Heart FJF, Beamis JF, Earnist A. History of rigid bronchoscopy. In : Earnist A, Mathur PN, Mehta AC. International Pulmonary Medicine; Marcell Dekker Inc; New York-USA; 2004 (1): 1-12
45.Ayers ML, Beamis JF. Rigid Bronchoscopy in The Twenty-Fisrt Century. Clin Chest Med. 2001; 22 (2): 355-63.
46.Prakash UBS, Cavaliere S. Bronchoscopy. In: Gold WM, Murray JF, Nadel JA. Atlas of Procedures in Respiratory Medicine. Saunders WB Company, Philadelphia-USA; 2002 (6): 241-65.
47.Adali F, Uysal A, Bayramoglu S, Guner NT, Yilmaz G, Cimilli T. Virtual and fiber-optic bronchoscopy in patients with indication for tracheobronchial evaluation. Ann Thorac Med. 2010 Apr-Jun; 5(2): 104–9. doi: 10.4103/1817-1737.62474. Diunduh pada tanggal 11 September 2012; 03.01 PM
48.Haas AR, Vachani A, Sterman DH. Advances in Diagnostic Bronchoscopy. Am J Respir Crit Care Med. 2010; 182: 589–97. Diunduh pada tanggal 11 September 2012; 02.51 PM
49.Freitag L, Macha HN. Interventional bronchoscopic procedures. In: Lung cancer. Eur Respir. 2001: 272-304. Diunduh pada tanggal 11 September 2012; 02.35 PM
51.Bourke SJ. Carcinoma of the lungs. In: Respiratory Medicine. 6th Ed. Blackwell Publishing Ltd. 2003:125-35.
52.Travis WD, Rekhtman N, Riley GJ, Geisinger KR, Asamura H, Brambilla E. Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift. Journal of Thoracic Oncology. 2010; 5: 4. Diunduh pada tanggal 7 September 2012; 03.51 AM
53.Fan YB, Wang QS, Ye L, Wang TY, Wu GP. Clinical application of the surepath liquid-based pap test in cytological screening of bronchial brushing for the diagnosis of lung cancer. Cytotechnology. 2010; 62:53–9. DOI 10.1007/s10616-010-9261-5. Diunduh pada tanggal 11 September 2012; 03.11 PM
54.Monaco SE, Schuchert MJ, Walid E. Khalbuss WE. Diagnostic difficulties and pitfalls in rapid on-site evaluation of endobronchial ultrasound guided fine needle aspiration. Cytojournal. 2010; 7: 9. Diunduh pada tanggal 11 September 2012; 08.08 PM
55.Ganjei-Azar P, Nadji M. Color Atlas of Immunocytochemistry in Diagnostic Cytology. Springer; 2007.p.1-152
56.Myong NH. Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: Its prognostic implication and relationship with expressions of p53 and KI-67 proteins. J Korean Med Sci. 2003; 18: 494-500. Diunduh pada tanggal 16 Agustus 2012; 04.10 PM
57.Cardoso WV. Lung morphogenesis, role of growth factors and transcription factors. In: Richard Harding R, Pinkerton KE, Plopper CG.(Eds).The Lung: Development, Aging and the Environment. Elsevier; 2004.p.3-12.
58.Kimura S. Thyroid-specific transcription factors and their roles in thyroid cancer. Journal of Thyroid Research. 2011; (2011): Article ID 710213, 8 pages. doi:10.4061/2011/710213. Diunduh pada tanggal 16 April 2012; 05.13 PM
59.Abutaily AS, Addis BJ, Roche WR. Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies. J Clin Pathol. 2002;55:662–8. Diunduh pada tanggal 16 Agustus 2012; 03.46 PM
non-pulmonary primary tumors. Appl Immunohistochem Mol Morphol. 2010 March ; 18(2): 142–9. Diunduh pada tanggal 16 April 2012; 05.23 PM
61.Hecht JL, Pinkus JL, Weinstein LJ, Pinkus GS. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin. Am J Clin Pathol 2001;116:483-8. Diunduh pada tanggal 27 Oktober 2013; 12.06 AM
62.Wu M, Wang B, Gil J, Sabo E, Miller L, Gan L, et al. p63 and TTF-1 immunostaining a useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Am J Clin Pathol 2003;119:696-702. Diunduh pada tanggal 27 Oktober 2013; 01.57 PM
63.Liu J, Farhood A. Immunostaining for thyroid transcription factor-1 on fine-needle aspiration specimens of lung tumors. Cancer. 2004; 102: 109–14. Diunduh pada tanggal 28 Oktober 2013; 02.24 AM
64.Liu J, Farhood A. Thyroid transcription factor-1 immunocytochemical staining of pleural fluid cytocentrifuge preparations for detection of small cell lung carcinoma. Acta Cytol. 2004; 48: 635-40. Diunduh pada tanggal 27 Oktober 2013; 03.29 PM
65.Kalhor N, Zander DS, Liu J. TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material. Modern Pathology.2006;19:1117–23. Diunduh pada tanggal 27 Oktober 2013; 12.16 AM
66.Sastroasmoro, S. Dasar-dasar Metodologi Penelitian Klinis. CV Sagung Seto. Jakarta. 2002.
